DrugBank Appoints Lisa Downey as CEO, Co-Founder Mike Wilson Moves to Chief Product Role

October 21, 2025
DrugBank has named Lisa Downey as its new CEO, with Co-Founder Mike Wilson transitioning to Chief Product Officer to focus on AI and data intelligence initiatives.

DrugBank has announced a leadership transition as it advances its AI-driven biomedical intelligence initiatives, according to a press release. Effective October 6, Lisa Downey has been appointed Chief Executive Officer, while Co-Founder Mike Wilson moves from CEO to Chief Product Officer.

Downey brings nearly two decades of experience in healthcare, life sciences, and data transformation, having previously held leadership roles at Clarivate and GlobalData. In her new role, she will oversee DrugBank’s next phase of AI-powered innovation and global growth.

As Chief Product Officer, Wilson will lead the development of DrugBank’s platform, expanding its use of machine learning and predictive modeling to enhance biomedical data accessibility for scientists and developers.

The leadership changes coincide with DrugBank’s upcoming twentieth anniversary in January, marking its evolution from a University of Alberta research project to a global biomedical intelligence platform serving clients across the pharmaceutical, biotech, academic, and healthcare sectors.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/21
Hyro Raises $45 Million to Expand AI Agents for Healthcare
10/21
Lightbeam Health Solutions Reports $444 Million in ACO Savings for 2024
10/21
Brook.ai Names Former Teladoc COO Mike Waters as Chairman of the Board
10/21
Tri-City Cardiology Expands AI Partnership with Basata
10/21
Family Health Choice Partners with MediKarma to Add AI Health Guidance

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Governing the Future: A Strategic Framework for AI Adoption in Financial Institutions

This whitepaper explores the transformative impact of artificial intelligence on the financial industry, focusing on the governance challenges and regulatory demands faced by banks. It provides a strategic framework for AI adoption, emphasizing the importance of a unified AI approach to streamline compliance and reduce operational costs. The document offers actionable insights and expert recommendations for banks with fewer than 2,000 employees to become leaders in compliant, customer-centric AI.

Read more

You May Also Like